Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.
Monge S, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Emborg HD, Sacco C, Mateo-Urdiales A, Castilla J, Martínez-Baz I, de Gier B, Hahné S, Meijerink H, Kristoffersen AB, Machado A, Soares P, Nardone A, Bacci S, Kissling E, Nunes B; VEBIS‐EHR Working Group. Monge S, et al. Among authors: sacco c. Influenza Other Respir Viruses. 2024 Apr;18(4):e13292. doi: 10.1111/irv.13292. Influenza Other Respir Viruses. 2024. PMID: 38654485 Free PMC article.
Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January-September 2021.
Sacco C, Mateo-Urdiales A, Petrone D, Spuri M, Fabiani M, Vescio MF, Bressi M, Riccardo F, Del Manso M, Bella A, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group. Sacco C, et al. Euro Surveill. 2021 Nov;26(47):2101001. doi: 10.2807/1560-7917.ES.2021.26.47.2101001. Euro Surveill. 2021. PMID: 34823637 Free PMC article.
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
Fabiani M, Puopolo M, Morciano C, Spuri M, Spila Alegiani S, Filia A, D'Ancona F, Del Manso M, Riccardo F, Tallon M, Proietti V, Sacco C, Massari M, Da Cas R, Mateo-Urdiales A, Siddu A, Battilomo S, Bella A, Palamara AT, Popoli P, Brusaferro S, Rezza G, Menniti Ippolito F, Pezzotti P; Italian Integrated Surveillance of covid-19 study group and Italian covid-19 Vaccines Registry group. Fabiani M, et al. Among authors: sacco c. BMJ. 2022 Feb 10;376:e069052. doi: 10.1136/bmj-2021-069052. BMJ. 2022. PMID: 35144968 Free PMC article.
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021.
Fabiani M, Puopolo M, Filia A, Sacco C, Mateo-Urdiales A, Spila Alegiani S, Del Manso M, D'Ancona F, Vescio F, Bressi M, Petrone D, Spuri M, Rota MC, Massari M, Da Cas R, Morciano C, Stefanelli P, Bella A, Tallon M, Proietti V, Siddu A, Battilomo S, Palamara AT, Popoli P, Brusaferro S, Rezza G, Riccardo F, Menniti Ippolito F, Pezzotti P. Fabiani M, et al. Among authors: sacco c. Expert Rev Vaccines. 2022 Jul;21(7):975-982. doi: 10.1080/14760584.2022.2064280. Epub 2022 Apr 15. Expert Rev Vaccines. 2022. PMID: 35389748 Free PMC article.
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
Sacco C, Del Manso M, Mateo-Urdiales A, Rota MC, Petrone D, Riccardo F, Bella A, Siddu A, Battilomo S, Proietti V, Popoli P, Menniti Ippolito F, Palamara AT, Brusaferro S, Rezza G, Pezzotti P, Fabiani M; Italian National COVID-19 Integrated Surveillance System and the Italian COVID-19 vaccines registry. Sacco C, et al. Lancet. 2022 Jul 9;400(10346):97-103. doi: 10.1016/S0140-6736(22)01185-0. Epub 2022 Jul 1. Lancet. 2022. PMID: 35780801 Free PMC article.
Differences in the incidence and clinical outcomes of SARS-CoV-2 infection between Italian and non-Italian nationals using routine data.
Fabiani M, Vescio MF, Bressi M, Mateo-Urdiales A, Petrone D, Spuri M, Sacco C, Del Manso M, Bella A, D'Ancona F, Rota MC, Filia A, Declich S, Marchetti G, Petrelli A, Di Napoli A, Riccardo F, Palamara AT, Pezzotti P; Italian Integrated Surveillance of COVID-19 Study Group. Fabiani M, et al. Among authors: sacco c. Public Health. 2022 Oct;211:136-143. doi: 10.1016/j.puhe.2022.07.022. Epub 2022 Aug 11. Public Health. 2022. PMID: 36113199 Free PMC article.
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A retrospective matched cohort study.
Fabiani M, Mateo-Urdiales A, Sacco C, Rota MC, Petrone D, Bressi M, Del Manso M, Siddu A, Proietti V, Battilomo S, Menniti-Ippolito F, Popoli P, Bella A, Riccardo F, Palamara AT, Rezza G, Brusaferro S, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group, of the Italian COVID-19 Vaccines Registry group. Fabiani M, et al. Among authors: sacco c. Vaccine. 2023 Jan 4;41(1):76-84. doi: 10.1016/j.vaccine.2022.11.013. Epub 2022 Nov 14. Vaccine. 2023. PMID: 36400660 Free PMC article.
Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
Petrone D, Mateo-Urdiales A, Sacco C, Riccardo F, Bella A, Ambrosio L, Lo Presti A, Di Martino A, Ceccarelli E, Del Manso M, Fabiani M, Stefanelli P, Pezzotti P, Palamara A; Italian Integrated Surveillance of COVID-19. Petrone D, et al. Among authors: sacco c. Int J Infect Dis. 2023 Apr;129:135-141. doi: 10.1016/j.ijid.2023.01.027. Epub 2023 Jan 26. Int J Infect Dis. 2023. PMID: 36708869 Free PMC article.
Protection against severe COVID-19 after second booster dose of adapted bivalent (original/Omicron BA.4-5) mRNA vaccine in persons ≥ 60 years, by time since infection, Italy, 12 September to 11 December 2022.
Fabiani M, Mateo-Urdiales A, Sacco C, Fotakis EA, Rota MC, Petrone D, Bressi M, Del Manso M, Siddu A, Fedele G, Stefanelli P, Bella A, Riccardo F, Palamara AT, Rezza G, Brusaferro S, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group and of the Italian COVID-19 Vaccines Registry group. Fabiani M, et al. Among authors: sacco c. Euro Surveill. 2023 Feb;28(8):2300105. doi: 10.2807/1560-7917.ES.2023.28.8.2300105. Euro Surveill. 2023. PMID: 36820640 Free PMC article.
217 results